NFKB1 and myeloid sarcoma: One study analyzing CD3+ T cells from RRMS patients discovered that out of 43 differentially expressed genes between acute relapse and complete remission, abnormal NFkB gene expression in T cells correlated most significantly with MS relapse [128].